That was the message of Day 1 of BIO’s Patient and Health Advocacy Digital Summit. Three takeaways that emerged include:
Trust is essential
Lessons from COVID-19 can improve outcomes for all patients.
The industry “should look like our nation
Patients are the Purpose: Patient Diversity in Clinical Trials